Zahra Mahmoudjafari, PharmD, BCOP, clinical pharmacy manager of Hematology/BMT/Cellular Therapeutics at University of Kansas Health System discussed CAR T-Cell therapies in managed care at the annual AMCP 2022 conference in Chicago.
Real-world studies are increasing as real-world data for new drugs for cancer and autoimmune disease have “matured,” says Laura E. Happe, Pharm.D., M.P.H., the editor-in-chief of Journal of Managed Care and Specialty Pharmacy.
Soumya Vishwanath, PharmD, senior manager of Formulary Strategy at Magellan Rx Management, talked about digital therapeutics in the behavioral health space and formulary strategy space during the annual AMCP 2022 conference in Chicago.
“Popping a pill” makes cancer treatment more convenient, but research presented at the AMCP annual meetings shows that almost half of cancer patients on oral therapies are nonadherent. Oral administration typically moves a drug to the pharmacy benefit, which can mean high out-of-pocket costs and, in turn, nonadherence.
Using a claims database, researchers found a steady increase in the prevalence of alopecia areata from 2016 to 2019 among those with employer-based health insurance. They also found a higher prevalence and incidence rate among women than among men.